healthcare
Angelini Ventures invests eight million euros in two U.S. startups
These are Noctrix Health and COUR Pharmaceuticals, which develop wearable therapy devices and nanotechnology to combat diabetes and celiac disease
These are Noctrix Health and COUR Pharmaceuticals, which develop wearable therapy devices and nanotechnology to combat diabetes and celiac disease